Hi Darren, thanks for your question.
At this stage it’s not clear if regenerative medicine research funded by the Appeal will have direct benefits for people with dilated cardiomyopathy. But it’s really too early to know for sure.
However, we’re well aware of the importance of the condition. The Appeal is funding research over and above our current research spend, so please be assured that we will continue to fund a great deal of research into the genetic and molecular causes of dilated cardiomyopathy in the hope that new treatments will emerge.
Thanks again and best wishes for the future